Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management

New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials

(2014) Partha Sardar et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD

(2014) Z. Harel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban

(2014) Jack E. Ansell et al.   NEW ENGLAND JOURNAL OF MEDICINE

On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation

(2014) Mika Skeppholm et al.   THROMBOSIS RESEARCH

Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population

(2013) Susan Colilla et al.   AMERICAN JOURNAL OF CARDIOLOGY

A specific antidote for dabigatran: functional and structural characterization

(2013) F. Schiele et al.   BLOOD

Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban

(2013) A. FAWOLE et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Novel Oral Anticoagulants in Atrial Fibrillation: A Meta-analysis of Large, Randomized, Controlled Trials vs Warfarin

(2013) Ariel Dogliotti et al.   CLINICAL CARDIOLOGY

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

(2013) Genmin Lu et al.   NATURE MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran monitoring made simple?

(2013) John W. Eikelboom et al.   THROMBOSIS AND HAEMOSTASIS

The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples

(2013) Jenny Butler et al.   THROMBOSIS AND HAEMOSTASIS

Long-Term Anticoagulation in the Extreme Elderly with the Newer Antithrombotics: Safe or Sorry?

(2013) Jun R Chiong et al.   Korean Circulation Journal

Letter by Bernstein et al Regarding Article, “Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects

(2012) Richard A. Bernstein et al.   CIRCULATION

Reversal of Warfarin

(2012) David A. Garcia et al.   CIRCULATION

Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis

(2012) J. Steffel et al.   EUROPEAN HEART JOURNAL

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

(2012) Stefan H. Hohnloser et al.   EUROPEAN HEART JOURNAL

Neurological Diseases in Relation to the Blood–Brain Barrier

(2012) Gary A Rosenberg   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Is home monitoring of international normalised ratio safer than clinic-based monitoring?

(2012) A. Cumberworth et al.   Interactive Cardiovascular and Thoracic Surgery

Use of warfarin in long-term care: a systematic review

(2012) Marjorie Neidecker et al.   BMC Geriatrics

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

Dabigatran Etexilate

(2011) Graeme J. Hankey et al.   CIRCULATION

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

(2011) K. A. A. Fox et al.   EUROPEAN HEART JOURNAL

Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor

(2011) Richard C. Becker et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergency Hospitalizations for Adverse Drug Events in Older Americans

(2011) Daniel S. Budnitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

(2010) Joachim Stangier et al.   CLINICAL PHARMACOKINETICS

Heart Disease and Stroke Statistics—2010 Update

(2009) et al.   CIRCULATION